BrainStorm Cell Therapeutics Q2 2025 Earnings Preview

* BrainStorm Cell Therapeutics (OTC:BCLI [https://seekingalpha.com/symbol/BCLI]) is scheduled to announce Q2 earnings results on Thursday, August 14th, before market open.
* The consensus EPS Estimate is -$0.33 [https://seekingalpha.com/symbol/BCLI/earnings/estimates].
* Over the last 1 year, BCLI has beaten EPS estimates [https://seekingalpha.com/symbol/BCLI/earnings/eps-surprise-summary] 25% of the time and has beaten revenue estimates 0% of the time.
* Over the last 3 months, EPS estimates have seen 1 upward revision [https://seekingalpha.com/symbol/BCLI/earnings/revisions] and 0 downward.

MORE ON BRAINSTORM CELL THERAPEUTICS

* Brainstorm Cell Therapeutics Inc. (BCLI) Q1 2025 Earnings Call Transcript [https://seekingalpha.com/article/4788173-brainstorm-cell-therapeutics-inc-bcli-q1-2025-earnings-call-transcript]
* BrainStorm Cell Therapeutics to move from Nasdaq to OTCQB after delisting; shares down [https://seekingalpha.com/news/4468668-brainstorm-cell-therapeutics-to-move-from-nasdaq-to-otcqb-after-delisting-shares-down]
* BrainStorm finalizes prior offering [https://seekingalpha.com/news/4462451-brainstorm-files-to-sell-276m-shares-of-common-stock-for-holders]
* Seeking Alpha’s Quant Rating on BrainStorm Cell Therapeutics [https://seekingalpha.com/symbol/BCLI/ratings/quant-ratings]
* Historical earnings data for BrainStorm Cell Therapeutics [https://seekingalpha.com/symbol/BCLI/earnings]